Sign in

CIK 0001882782 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Odyssey Therapeutics, Inc.

Sign in to watch
Ticker
ODTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863384382
Phone
(212) 841-1000
Business address
51 SLEEPER STREET, BOSTON, MA, 02210
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Regulation FD disclosure
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Regulation FD disclosure
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13D Stake Beneficial Ownership Report
  14. SCHEDULE 13D Stake Beneficial Ownership Report
  15. SCHEDULE 13D Stake Beneficial Ownership Report
  16. SCHEDULE 13D Stake Beneficial Ownership Report
  17. 4 Open-market buy Former 10% Owner bought 1,388,889 shares at $18.00 ($25,000,002)
  18. 4 Open-market buy Director bought 1,111,111 shares at $18.00 ($19,999,998)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy 10% owner bought 555,555 shares at an average $18.00 ($9,999,990)

Page 1 of 4 · 72 filings